Rankings
▼
Calendar
TCRX Q1 2020 Earnings — TScan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
TCRX
TScan Therapeutics, Inc.
$65M
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$4M
Operating Income
-$6M
Net Income
-$6M
EPS (Diluted)
$-0.23
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$6M
Stock-Based Comp.
$111,000
← FY 2020
All Quarters
Q2 2020 →